Cinpride

Cinpride Uses, Dosage, Side Effects, Food Interaction and all others data.

Cinpride is a gastroprokinetic agent and antiulcer benzamide with agonist activity at 5-HT1 and 5-HT4 receptors and antagonist activity at 5-HT2 receptors. It is marketed in Spain and Mexico.

Cinpride
Uses
Dosage
Side Effect
Precautions
Interactions
Uses during Pregnancy
Uses during Breastfeeding
Accute Overdose
Food Interaction
Half Life
Volume of Distribution
Clearance
Interaction With other Medicine
Contradiction
Storage

Trade Name	Cinpride
Generic	Cinitapride
Cinitapride Other Names	Cinitaprida, Cinitapride, Cinitapridum
Weight	1mg/5ml,
Type	Syrup, Tablet
Formula	C₂₁H₃₀N₄O₄
Weight	Average: 402.4873 Monoisotopic: 402.226705468
Groups	Investigational
Therapeutic Class
Manufacturer	Kaizen Pharmaceuticals Pvt Ltd,, Iva Healthcare Pvt Ltd
Available Country	Pakistan, India
Last Updated:	September 19, 2023 at 7:00 am

Uses

Cinpride is a benzamide with gastroprokinetic and antiemetic properties typically used for the treatment of gastrointestinal motility disorders such as gastroesophageal reflux disease (GERD), non-ulcer dyspepsia, and delayed gastric emptying.

It is indicated to treat gastrointestinal disorders associated with motility disturbances like gastroesophageal reflux disease (GERD), non-ulcer dyspepsia and delayed gastric emptying.

Cinpride is also used to associated treatment for these conditions: Dyspepsia, Flatulence, Gastro-esophageal Reflux Disease (GERD), Gastroesophageal Reflux, Decreased gastrointestinal motility, Meteorism, Mild Dyspepsia, Moderate Dyspepsia

How Cinpride works

Cinpride is a substituted benzamide with 5-HT receptor antagonist and agonist activity.

Toxicity

The symptoms of overdose include drowsiness, confusion and extrapyramidal effects.

Elimination Route

The absorption of cinitapride (12mg) following oral administration was rapid, with peak levels being achieved 2 h after dosing; absorption following intramuscular administration (4mg) was even more rapid, with peak levels (50% more that oral levels) being achieved 1 h after dosing.